PainChek gains access to RTM reimbursement in USA

• Independent US legal opinion confirms PainChek qualifies as an FDA-regulated medical device for Remote Therapeutic Monitoring (RTM) reimbursement through US Centre for Medicare & Medicaid Services (CMS) • PainChek recently granted FDA De Novo classification as a medical device enabling access to the significant musculoskeletal segment of RTM reimbursement framework • PainChek is the only FDA-cle